Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 7
2004 11
2005 7
2006 3
2007 7
2008 11
2009 3
2010 6
2011 7
2012 8
2013 13
2014 14
2015 21
2016 13
2017 8
2018 11
2019 13
2020 16
2021 13
2022 15
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.
Tamaki N, Higuchi M, Keitoku T, Yamazaki Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Okada R, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Kanto T, Kurosaki M, Izumi N. Tamaki N, et al. Among authors: nakanishi h. JGH Open. 2024 Apr 25;8(4):e13067. doi: 10.1002/jgh3.13067. eCollection 2024 Apr. JGH Open. 2024. PMID: 38665298 Free PMC article.
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Suzuki K, Yasui Y, Tsuchiya K, Matsumoto H, Yamazaki Y, Uchihara N, Tanaka Y, Miyamoto H, Yamada-Shimizu M, Keitoku T, Okada R, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Nakanishi H, Takahashi Y, Asahina Y, Okamoto R, Kurosaki M, Izumi N. Suzuki K, et al. Among authors: nakanishi h. J Gastroenterol Hepatol. 2024 Mar 17. doi: 10.1111/jgh.16532. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38494668
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.
Suzuki K, Tamaki N, Kurosaki M, Takahashi Y, Yamazaki Y, Uchihara N, Tanaka Y, Miyamoto H, Yamada M, Keitoku T, Okada R, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Izumi N. Suzuki K, et al. Among authors: nakanishi h. Hepatol Res. 2024 Jan 17. doi: 10.1111/hepr.14011. Online ahead of print. Hepatol Res. 2024. PMID: 38234088
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.
Kirino S, Tamaki N, Kurosaki M, Takahashi Y, Higuchi M, Itakura Y, Tanaka Y, Inada K, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Kirino S, et al. Among authors: nakanishi h. Quant Imaging Med Surg. 2023 Oct 1;13(10):6493-6502. doi: 10.21037/qims-23-511. Epub 2023 Aug 28. Quant Imaging Med Surg. 2023. PMID: 37869309 Free PMC article.
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
Yamada-Shimizu M, Tamaki N, Kurosaki M, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Ishido S, Nobusawa T, Matsumoto H, Keitoku T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Izumi N. Yamada-Shimizu M, et al. Among authors: nakanishi h. Intern Med. 2023 Sep 29. doi: 10.2169/internalmedicine.2248-23. Online ahead of print. Intern Med. 2023. PMID: 37779070 Free article.
Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.
Ishido S, Tamaki N, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Itakura J, Kurosaki M, Izumi N. Ishido S, et al. Among authors: nakanishi h. JGH Open. 2023 Jul 21;7(8):567-571. doi: 10.1002/jgh3.12950. eCollection 2023 Aug. JGH Open. 2023. PMID: 37649865 Free PMC article.
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.
Ishido S, Tamaki N, Inada K, Itakura J, Takahashi Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Kurosaki M, Izumi N. Ishido S, et al. Among authors: nakanishi h. Clin Case Rep. 2023 Jul 5;11(7):e7664. doi: 10.1002/ccr3.7664. eCollection 2023 Jul. Clin Case Rep. 2023. PMID: 37415592 Free PMC article.
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.
Ishido S, Tamaki N, Takahashi Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Kurosaki M, Izumi N. Ishido S, et al. Among authors: nakanishi h. BMC Gastroenterol. 2023 Jun 17;23(1):211. doi: 10.1186/s12876-023-02848-7. BMC Gastroenterol. 2023. PMID: 37330485 Free PMC article.
201 results